A barbed end interference mechanism reveals how capping protein promotes nucleation in branched actin networks.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
09 09 2021
Historique:
received: 10 04 2021
accepted: 18 08 2021
entrez: 10 9 2021
pubmed: 11 9 2021
medline: 7 10 2021
Statut: epublish

Résumé

Heterodimeric capping protein (CP/CapZ) is an essential factor for the assembly of branched actin networks, which push against cellular membranes to drive a large variety of cellular processes. Aside from terminating filament growth, CP potentiates the nucleation of actin filaments by the Arp2/3 complex in branched actin networks through an unclear mechanism. Here, we combine structural biology with in vitro reconstitution to demonstrate that CP not only terminates filament elongation, but indirectly stimulates the activity of Arp2/3 activating nucleation promoting factors (NPFs) by preventing their association to filament barbed ends. Key to this function is one of CP's C-terminal "tentacle" extensions, which sterically masks the main interaction site of the terminal actin protomer. Deletion of the β tentacle only modestly impairs capping. However, in the context of a growing branched actin network, its removal potently inhibits nucleation promoting factors by tethering them to capped filament ends. End tethering of NPFs prevents their loading with actin monomers required for activation of the Arp2/3 complex and thus strongly inhibits branched network assembly both in cells and reconstituted motility assays. Our results mechanistically explain how CP couples two opposed processes-capping and nucleation-in branched actin network assembly.

Identifiants

pubmed: 34504078
doi: 10.1038/s41467-021-25682-5
pii: 10.1038/s41467-021-25682-5
pmc: PMC8429771
doi:

Substances chimiques

Actin Capping Proteins 0
Actin-Related Protein 2-3 Complex 0
Actins 0
Gelsolin 0
Intercellular Signaling Peptides and Proteins 0
Profilins 0
Recombinant Proteins 0
WASL protein, human 0
Wiskott-Aldrich Syndrome Protein, Neuronal 0
myotrophin 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5329

Informations de copyright

© 2021. The Author(s).

Références

Sci STKE. 2004 Feb 03;2004(219):pl2
pubmed: 14872095
J Cell Biol. 2006 Dec 18;175(6):947-55
pubmed: 17178911
Biophys J. 2008 Mar 1;94(5):1826-35
pubmed: 17921203
Cell. 2008 May 30;133(5):841-51
pubmed: 18510928
Nature. 1999 Oct 7;401(6753):613-6
pubmed: 10524632
Nat Methods. 2017 Aug;14(8):793-796
pubmed: 28671674
Nature. 2009 Jan 22;457(7228):441-5
pubmed: 19158791
Physiol Rev. 2014 Jan;94(1):235-63
pubmed: 24382887
Cell. 2012 Mar 2;148(5):973-87
pubmed: 22385962
Nucleic Acids Res. 2014 Dec 16;42(22):e168
pubmed: 25300484
J Struct Biol. 2007 Jan;157(1):38-46
pubmed: 16859925
Adv Exp Med Biol. 2007;607:97-110
pubmed: 17977462
Nat Struct Mol Biol. 2020 Nov;27(11):1009-1016
pubmed: 32839613
Science. 2015 Mar 27;347(6229):1441-1446
pubmed: 25814576
Nat Commun. 2020 Nov 11;11(1):5716
pubmed: 33177513
Nat Cell Biol. 2001 Jan;3(1):76-82
pubmed: 11146629
J Struct Biol. 2020 Oct 1;212(1):107579
pubmed: 32693019
Curr Protoc Protein Sci. 2017 Aug 1;89:15.3.1-15.3.19
pubmed: 28762490
Sci Adv. 2021 Jan 27;7(5):
pubmed: 33571120
J Struct Biol. 2015 Nov;192(2):216-21
pubmed: 26278980
Biophys Rev. 2018 Dec;10(6):1537-1551
pubmed: 30470968
Nat Commun. 2015 Nov 13;6:8707
pubmed: 26566078
Biophys J. 2005 Feb;88(2):1387-402
pubmed: 15556992
Cell. 2017 Sep 21;171(1):188-200.e16
pubmed: 28867286
Nat Rev Mol Cell Biol. 2014 Oct;15(10):677-89
pubmed: 25207437
EMBO J. 2008 Apr 9;27(7):982-92
pubmed: 18309290
Curr Biol. 2010 Mar 9;20(5):423-8
pubmed: 20188562
J Vis Exp. 2017 May 16;(123):
pubmed: 28570515
Methods Mol Biol. 2013;1046:231-50
pubmed: 23868592
Nat Rev Mol Cell Biol. 2013 Jan;14(1):7-12
pubmed: 23212475
J Mol Biol. 2010 Dec 17;404(5):794-802
pubmed: 20969875
Methods Enzymol. 2011;498:349-61
pubmed: 21601685
Cell. 2016 Jan 14;164(1-2):115-127
pubmed: 26771487
IUCrJ. 2019 Jan 01;6(Pt 1):5-17
pubmed: 30713699
Mol Reprod Dev. 1998 Jan;49(1):81-91
pubmed: 9406198
Nat Biotechnol. 2003 Jan;21(1):86-9
pubmed: 12469133
Curr Biol. 2021 Mar 22;31(6):1192-1205.e6
pubmed: 33561386
J Biol Methods. 2014;1(2):
pubmed: 25606571
Commun Biol. 2021 Jul 15;4(1):874
pubmed: 34267316
Methods Mol Biol. 2008;426:145-59
pubmed: 18542861
Curr Biol. 2017 Apr 24;27(8):R318-R326
pubmed: 28441569
Structure. 2020 Apr 7;28(4):437-449.e5
pubmed: 32084355
Dev Cell. 2015 Jan 12;32(1):54-67
pubmed: 25543281
J Cell Biol. 1994 Oct;127(2):453-65
pubmed: 7929588
Curr Biol. 2003 Sep 2;13(17):1531-7
pubmed: 12956956
Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):486-501
pubmed: 20383002
Nature. 1980 Dec 4;288(5790):455-9
pubmed: 6893736
Nat Struct Mol Biol. 2018 Jun;25(6):528-537
pubmed: 29867215
Proc Natl Acad Sci U S A. 2005 Nov 15;102(46):16644-9
pubmed: 16275905
Nat Commun. 2015 Nov 13;6:8730
pubmed: 26564775
Nature. 2018 Feb 7;554(7691):202-206
pubmed: 29420470
J Biol Chem. 2007 Sep 21;282(38):28014-24
pubmed: 17656356
EMBO J. 2018 Jan 4;37(1):102-121
pubmed: 29141912
J Cell Sci. 1999 Nov;112 ( Pt 21):3779-90
pubmed: 10523513
Nat Methods. 2006 Nov;3(11):891-3
pubmed: 17013382
Methods Mol Biol. 2013;1046:145-70
pubmed: 23868587
J Cell Biol. 2018 May 7;217(5):1827-1845
pubmed: 29507127
EMBO J. 2006 Nov 29;25(23):5626-33
pubmed: 17110933
Nat Cell Biol. 2021 Feb;23(2):147-159
pubmed: 33558729
Elife. 2019 Oct 24;8:
pubmed: 31647411
EMBO J. 2003 Apr 1;22(7):1529-38
pubmed: 12660160
Curr Opin Cell Biol. 2021 Feb;68:37-44
pubmed: 32977244
Acta Crystallogr D Struct Biol. 2018 Jun 1;74(Pt 6):519-530
pubmed: 29872003
J Cell Biol. 2010 Nov 1;191(3):571-84
pubmed: 21041447
Curr Biol. 2001 Jan 23;11(2):130-5
pubmed: 11231131
Cell Motil Cytoskeleton. 1997;38(2):120-32
pubmed: 9331217
Phys Biol. 2015 Nov 25;12(6):066008
pubmed: 26602226
J Cell Biol. 2004 Feb 16;164(4):567-80
pubmed: 14769858
Nat Methods. 2017 Apr;14(4):331-332
pubmed: 28250466
Curr Opin Cell Biol. 2019 Feb;56:7-13
pubmed: 30193157
Commun Biol. 2019 Jun 19;2:218
pubmed: 31240256
Curr Biol. 2018 Dec 3;28(23):3886-3891.e4
pubmed: 30471998
Front Immunol. 2020 Jun 12;11:1097
pubmed: 32595635
Cell. 2007 Mar 9;128(5):901-13
pubmed: 17350575
Nat Methods. 2008 Jul;5(7):605-7
pubmed: 18536722
Elife. 2013 Sep 03;2:e00884
pubmed: 24015358
Structure. 2012 Feb 8;20(2):237-47
pubmed: 22325773
Cell. 1995 May 19;81(4):591-600
pubmed: 7758113
J Cell Biol. 1996 Oct;135(1):169-79
pubmed: 8858171
Cytoskeleton (Hoboken). 2011 Nov;68(11):596-602
pubmed: 22002930
Curr Biol. 2007 Mar 6;17(5):395-406
pubmed: 17331727
Cell. 2004 Aug 6;118(3):363-73
pubmed: 15294161
Biochemistry. 1985 Jan 29;24(3):793-9
pubmed: 3994986
Int Rev Cell Mol Biol. 2008;267:183-206
pubmed: 18544499
J Cell Sci. 2012 Jun 1;125(Pt 11):2775-85
pubmed: 22431015
J Struct Biol. 2012 Dec;180(3):519-30
pubmed: 23000701

Auteurs

Johanna Funk (J)

Department of Systemic Cell Biology, Max Planck Institute of Molecular Physiology, Dortmund, Germany.

Felipe Merino (F)

Department of Structural Biochemistry, Max Planck Institute of Molecular Physiology, Dortmund, Germany.
Department of Protein Evolution, Max Planck Institute for Developmental Biology, Tübingen, Germany.

Matthias Schaks (M)

Division of Molecular Cell Biology, Zoological Institute, Technische Universität Braunschweig, Braunschweig, Germany.
Department of Cell Biology, Helmholtz Centre for Infection Research, Braunschweig, Germany.

Klemens Rottner (K)

Division of Molecular Cell Biology, Zoological Institute, Technische Universität Braunschweig, Braunschweig, Germany.
Department of Cell Biology, Helmholtz Centre for Infection Research, Braunschweig, Germany.

Stefan Raunser (S)

Department of Structural Biochemistry, Max Planck Institute of Molecular Physiology, Dortmund, Germany. Stefan.Raunser@mpi-dortmund.mpg.de.

Peter Bieling (P)

Department of Systemic Cell Biology, Max Planck Institute of Molecular Physiology, Dortmund, Germany. Peter.Bieling@mpi-dortmund.mpg.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH